NSM Insurance Group, which is backed by The Carlyle Group, has agreed to sell its US commercial insurance unit to New Mountain Capital. No financial terms were disclosed. The deal is expected to close ...

Shares of bluebird bio (NASDAQ:BLUE) continued their downward descent Monday in the wake of news that the company has been agreed to be taken private by Carlyle Group (NASDAQ:CG) and SK Capital ...

NSM Insurance Group, a global specialty insurance provider, has signed a definitive agreement to sell its US commercial ...

Voytek Podobas, founder of Podobas Global Investments, has exited his 6% stake in Kaonavi, Inc. (4435.T), a Tokyo Stock ...

Principal Financial Group Inc. decreased its holdings in shares of The Carlyle Group Inc. (NASDAQ:CG – Free Report) by 0.7% in the 4th quarter, Holdings Channel.com reports. The institutional investor ...

Markets worldwide defied expectations in 2024 led by the dominating performance of mega-cap technology stocks known as the ...

Cash-strapped gene-therapy company Bluebird bio agreed to be acquired by private-equity firms Carlyle Group and SK Capital ...

The pioneering gene therapy developer will be acquired by investment firms Carlyle Group and SK Capital for a fraction of ...

Former NBA player Michael Carter-Williams is hoping to get a WNBA franchise in Boston whether it's through expansion a ...

Somerville gene therapy company bluebird bio, once among the highest-profile biotechs in the Boston area, has agreed to be ...

The agreement, which also includes a team of biotech executives, will see Bluebird Bio’s stockholders receive $3.00 per share ...